How Will The Hospital And Nursing Home Probiotics Market Expand At A CAGR Of 11.3% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Hospital And Nursing Home Probiotics Market Valuation Change Between Now And 2029?
The probiotics market in hospitals and nursing homes has seen swift growth over the last few years. The market, which stood at $1.51 billion in 2024, is projected to increase to $1.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. Factors contributing to growth in the historical timeframe include a heightened awareness of gut health, a surge in gastrointestinal disorder cases, an embrace of probiotics in healthcare infrastructures, and mounting evidence underscoring the health advantages of probiotics.
The market size of probiotics used in hospitals and nursing homes is predicted to experience substantial expansion in the approaching years, hitting $2.58 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 11.3%. Several factors drive this projected growth, including the widespread adoption of probiotics, increasing need for solutions related to digestive health, growing consciousness about the benefits of probiotics, emphasis on curbing hospital-acquired infections (HAIs), and escalating investments in probiotic-based medical nutrition. The period of forecast will be marked by trends such as advancements in preparation of probiotics, enhancements in the delivery methods suited for specific healthcare environments, innovative uses of probiotics for preventing infection, production of specialized probiotics for the elderly and those with compromised immunity, alongside the infusion of digital solutions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20834&type=smp
What Growth-Enabling Forces Are Impacting The Hospital And Nursing Home Probiotics Market?
The surge in gastrointestinal disorders is projected to stimulate the expansion of the hospital and nursing home probiotics market. Gastrointestinal ailments involve a variety of conditions impacting the digestive system, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. Factors contributing to the upswing in these disorders include unhealthy eating patterns, increased intake of processed food, inactive lifestyles, and heightened stress levels. Probiotics used in hospitals and nursing homes aid in regulating gastrointestinal disorders by restoring the equilibrium of beneficial gut bacteria, enhancing digestive health, and mitigating symptoms like diarrhea, constipation, and bloating. For example, as reported by the IBD Registry, a non-profit organization based in the UK, by December 2023, the count of individuals diagnosed with Inflammatory Bowel Disease (IBD) crossed 5,300, an increase of more than 3,000 members relative to 2022. Consequently, the escalating occurrence of gastrointestinal disorders is fueling the growth of the hospital and nursing home probiotics market.
What Are The Main Segment Classifications In The Hospital And Nursing Home Probiotics Market?
The hospital and nursing home probioticsmarket covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea; Irritable Bowel Syndrome; Clostridium difficile Infection; Inflammatory Bowel Disease; General Gut Health
2) By Formulation Type: Capsules; Powder; Liquid; Soft Chew; Probiotic Yogurt
3) By Patient Group: Infants; Adults; Elderly; Immunocompromised Patients; Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals; Nursing Homes; Pharmacies; Online Retail; Healthcare Facilities
5) By Application: Gut Health; Immunity; Wellness; Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD; Treatment of AAD
2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D); IBS With Constipation (IBS-C); Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence; Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease; Ulcerative Colitis
5) By General Gut Health: Immune System Support; Digestive Health; Gut Microbiome Restoration
How Are Industry Trends Steering The Expansion Of The Hospital And Nursing Home Probiotics Market?
Leading firms in the hospital and nursing home probiotics market are concentrating their efforts on pioneering innovative probiotic solutions such as those that improve patient intestinal health, minimize recovery periods and alleviate antibiotic-related side effects. Probiotic solutions consist of products that contain live microorganisms, which when consumed in sufficient quantities, can offer health advantages principally by enhancing the ratio of beneficial bacteria in the digestive system. A case in point is Probi AB, a biotechnology business based in Sweden that specializes in probiotics, which launched Metabolic Health by Probi for healthcare environments in October 2024. This is a probiotic solution, clinically proven to support metabolic health, cardiovascular wellness, weight control, and regulation of blood pressure. It combines two exclusive probiotic strains, namely Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).
Which Firms Are Driving Innovation Within The Hospital And Nursing Home Probiotics Market?
Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods Group, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Hospital And Nursing Home Probiotics Market?
North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20834&type=smp
Browse Through More Reports Similar to the Global Hospital And Nursing Home Probiotics Market 2025, By The Business Research Company
Probiotics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report
Probiotics Dietary Supplements Global Market Report 2025
Probiotics Food And Cosmetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
